RHYTHM PHARMACEUTICALS INC. - COMMON STOCK
39.14
10-May-24 15:59:57
15 minutes delayed
Stocks
+0.64
+1.66%
Today's range
38.14 - 39.60
ISIN
N/A
Source
NASDAQ
-
17 Jun 2023 14:01:00 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference
07 Jun 2023 08:00:01 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
06 Jun 2023 16:01:00 By Nasdaq GlobeNewswire
-
22 May 2023 08:00:00 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
05 May 2023 16:01:00 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Update
02 May 2023 07:00:01 By Nasdaq GlobeNewswire
-
24 Apr 2023 07:00:00 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals to Report First Quarter 2023 Financial Results on Tuesday, May 2, 2023
18 Apr 2023 08:00:01 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference
10 Apr 2023 08:00:00 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
06 Apr 2023 16:01:00 By Nasdaq GlobeNewswire
-
27 Mar 2023 08:00:00 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
06 Mar 2023 16:01:00 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
01 Mar 2023 07:00:02 By Nasdaq GlobeNewswire
-
27 Feb 2023 08:45:00 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
08 Feb 2023 08:00:01 By Nasdaq GlobeNewswire
-
23 Jan 2023 08:00:01 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
05 Jan 2023 16:01:00 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
07 Dec 2022 16:01:00 By Nasdaq GlobeNewswire
-
Rhythm Pharmaceuticals to Present at BofA Securities 2022 Virtual Biotech SMID Cap Conference
01 Dec 2022 08:00:01 By Nasdaq GlobeNewswire